Genome-wide analysis identifies rare copy number variations associated with inflammatory bowel disease-Reference-Cited by-同舟云学术

Genome-wide analysis identifies rare copy number variations associated with inflammatory bowel disease

Published:2019-06-11 Issue:6 Volume:14 Page:e0217846
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Frenkel Svetlana^ORCID,Bernstein Charles N.,Sargent Michael,Kuang Qin,Jiang Wenxin,Wei John,Thiruvahindrapuram Bhooma,Spriggs Elizabeth,Scherer Stephen W.,Hu Pingzhao

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Epidemiology and risk factors for IBD;AN Ananthakrishnan;Nat Rev Gastroenterol Hepatol. Nature Publishing Group,2015

2. Inflammatory bowel disease: a Canadian burden of illness review;A Rocchi;Can J Gastroenterol,2012

3. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations;JZ Liu;Nat Genet,2015

4. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease;KM de Lange;Nat Genet,2017

5. The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead;AD Kostic;Gastroenterology,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Differential Gene Expression Based Simulated Annealing for Solving Gene Selection Problem: A Case Study on Eosinophilic Esophagitis and Few Other Gastro-Intestinal Diseases;2024-05-05

2. AMPFLDAP: Adaptive Message Passing and Feature Fusion on Heterogeneous Network for LncRNA-Disease Associations Prediction;Interdisciplinary Sciences: Computational Life Sciences;2024-04-06

3. Clinical Significance of Changes in Serum Biochemical Indices, Blood Routine and Coagulation Function in Patients with Inflammatory Bowel Disease;Advances in Clinical Medicine;2024

4. Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy;Stem Cells Translational Medicine;2023-02-01

5. Genetic modifiers of synucleinopathies—lessons from experimental models;Oxford Open Neuroscience;2023